Quarterly Metrics: Quick and Current Ratios for Clearside Biomedical Inc (CLSD)

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.92 million shares were traded. CLSD stock price reached its highest trading level at $1.05 during the session, while it also had its lowest trading level at $1.0.

Ratios:

To gain a deeper understanding of CLSD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 5.07.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on August 21, 2024, initiated with a Buy rating and assigned the stock a target price of $6.

On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 24 ’24 when Chong Ngai Hang Victor bought 23,500 shares for $1.06 per share. The transaction valued at 24,910 led to the insider holds 63,500 shares of the business.

YERXA BENJAMIN R bought 7,813 shares of CLSD for $10,235 on May 15 ’24. The Director now owns 17,957 shares after completing the transaction at $1.31 per share. On Apr 18 ’24, another insider, Gibney Anthony S, who serves as the Director of the company, bought 93,290 shares for $1.30 each. As a result, the insider paid 121,277 and bolstered with 100,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 75493056 and an Enterprise Value of 93727024. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.04. Its current Enterprise Value per Revenue stands at 12.457 whereas that against EBITDA is -3.653.

Stock Price History:

Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -11.62%, while the 200-Day Moving Average is calculated to be -19.60%.

Shares Statistics:

It appears that CLSD traded 172.58K shares on average per day over the past three months and 256170 shares per day over the past ten days. A total of 74.75M shares are outstanding, with a floating share count of 63.26M. Insiders hold about 15.36% of the company’s shares, while institutions hold 21.28% stake in the company. Shares short for CLSD as of 1722384000 were 206864 with a Short Ratio of 1.04, compared to 1719532800 on 226918. Therefore, it implies a Short% of Shares Outstanding of 206864 and a Short% of Float of 0.29.

Most Popular